Job Code: SS2 11-14-2019
The Holt Laboratory at BC Cancer is looking for a qualified candidate to aid in the preclinical and clinical development of novel cancer vaccines and cellular immunotherapies. The candidate will work with local, national and international partners, collaborators and service providers in academia, industry, government and not-for-profit organizations.
The successful candidate will have a PhD or equivalent degree and at least seven years of relevant experience. Knowledge of and research experience with standard methods and approaches in microbiology, immunology, cell biology, molecular biology, genomics and proteomics; and familiarity with the fields of cancer immunology and immunotherapy are assets. A strong background in preclinical and clinical research methodology is highly desirable.
The applicant should also demonstrate the ability to work independently, supervise trainees and technical staff, and conceive, initiate, prioritize, organize and manage multiple concurrent projects. Excellent verbal and written communication skills are a necessity as well as the ability to work in a team environment. Management experience with large, multi-center projects is an asset.
This position will begin ASAP. This is a one-year term appointment subject to annual renewal. Salary will be commensurate with qualifications and experience.
Applications, accompanied by a detailed curriculum vitae and three letters of reference addressing scholarly, professional and creative work, plus supervisory and administrative service, should be directed to:
Rob Holt, PhD
Scientific Co-Director, BC Cancer Immunotherapy Program
Distinguished Scientist, Canada's Michael Smith Genome Sciences Centre
Professor of Medical Genetics, University of British Columbia
Professor of Molecular Biology & Biochemistry, Simon Fraser University
This position will remain open until filled.
This is a temporary position with a possibility of extension.